Table 1.
Clinical baseline characteristics of patients.
| Baseline characteristics | Urokinase-type plasminogen activator (45) | Tissue-type plasminogen activator (41) | p-Value |
|---|---|---|---|
| Female, n (%) | 21 (46.7) | 20 (48.8) | 0.845 |
| Age (years) | 59.8 ± 9.0 | 56.7 ± 11.2 | 0.336 |
| SBP (mmHg) | 159.8 ± 24.8 | 162.1 ± 20.7 | 0.766 |
| HV (mL) | 54.2 ± 13.2 | 56.7 ± 11.2 | 0.556 |
| Direction (left/right) | 24/21 | 19/22 | 0.517 |
| GCS (score) | 8.9 ± 2.6 | 9.4 ± 2.9 | 0.595 |
| APACHE II (score) | 35.5 ± 9.5 | 34.1 ± 9.7 | 0.645 |
| Intracerebral hemorrhage score (score) | 2.6 ± 0.7 | 2.4 ± 0.6 | 0.266 |
| IVH, n (%) | 8 (17.8) | 9 (21.9) | 0.627 |
| Diabetes, n (%) | 8 (17.8) | 6 (14.6) | 0.693 |
| Hypertension, n (%) | 31 (68.9) | 30 (73.2) | 0.662 |
SBP, systolic blood pressure; HV, hematoma volume; GCS, Glasgow Coma Scale; APACHE II, Acute Physiology and Chronic Health Evaluation II; IVH, intraventricular hemorrhage.